盛和資源(600392.SH)擬定增募資不超13.68億元 用於建設稀土冶煉分離生產線等
格隆匯5月28日丨盛和資源(600392.SH)公佈2021年度非公開發行A股股票預案,本次非公開發行A股股票的數量不超過1.06億股(含),即不超過本次發行前總股本的6.04%,發行對象為不超過35名特定投資者,募資總額不超過13.68億元(含),募資淨額將全部用於“盛和資源(江蘇)稀土有限公司稀土冶煉分離生產線建設項目”、“稀土金屬加工技改擴產項目”、“晨光年產12,000噸稀土金屬及合金智能化技改項目”、“樂山科百瑞稀土金屬深加工技術升級改造項目”、“盛和德昌2,000噸/年稀土金屬深加工項目”、“研發中心及信息中心建設項目”、“環保設施升級項目”及補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.